Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stromal vascular fraction (SVF) is a heterogeneous mixture of cells derived from adipose tissue, primarily obtained via liposuction and enzymatic digestion. It is composed of various cell types, including adipose-derived stem cells (ADSCs), endothelial cells, endothelial progenitor cells, pericytes, and immune cells. SVF is investigated for its regenerative and immunomodulatory potential in a range of clinical applications, including wound healing, fat grafting, and reproductive disorders. The mechanisms of action include differentiation of ADSCs, secretion of growth factors and cytokines, and direct cell-cell interactions to promote tissue repair, angiogenesis, and immunomodulation. However, challenges remain regarding standardization, safety, and efficacy.
Multiple mechanisms, including differentiation of ADSCs, secretion of growth factors and cytokines, and direct cell-cell interactions to promote tissue repair, angiogenesis, and immunomodulation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stromal Vascular Fraction (SVF).